Acute Exacerbations of COPD: Delay in Presentation and the Risk of Hospitalization

REFERENCES

• Mannino D M, Homa D M, Akinbami L J, Ford E S, Redd S C. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ 2002; 51: 1–16
   PubMed Web of Science ®Google Scholar
• Chandra D, Guntupalli K K, Guleria R. Hypotension is a predictor of mortality in acute exacerbations of chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci 2007; 49: 13–18
   PubMedGoogle Scholar
• Connors A F, Jr., Dawson N V, Thomas C, Harrell F E, Jr., Desbiens N, Fulkerson W J, Kussin P, Bellamy P, Goldman L, Knaus W A. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154: 959–967
   PubMed Web of Science ®Google Scholar
• Wilkinson T M, Donaldson G C, Hurst J R, Seemungal T A, Wedzicha J A. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169: 1298–1303
   PubMed Web of Science ®Google Scholar
• Davies L, Angus R M, Calverley P M. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999; 354: 456–460
   PubMed Web of Science ®Google Scholar
• Niewoehner D E, Erbland M L, Deupree R H, Collins D, Gross N J, Light R W, Anderson P, Morgan N A. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999; 340: 1941–1947
   PubMed Web of Science ®Google Scholar
• Aaron S D, Vandemheen K L, Hebert P, Dales R, Stiell I G, Ahuja J, Dickinson G, Brison R, Rowe B H, Dreyer J, Yetisir E, Cass D, Wells G. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003; 348: 2618–2625
   PubMed Web of Science ®Google Scholar
• Cydulka R K, Rowe B H, Clark S, Emerman C L, Camargo C A, Jr. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: the Multicenter Airway Research Collaboration. J Am Geriatr Soc 2003; 51: 908–916
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117: 398S–401S
   PubMed Web of Science ®Google Scholar
• Pauwels R A, Buist A S, Calverley P M, Jenkins C R, Hurd S S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256–1276
   PubMedGoogle Scholar
• Radeos M S, Rowe B H, Clark S, Barr R G, Camargo C A, Jr. Validation of self-reported COPD among patients in the emergency department. Am J Emerg Med 2008, In press
   Google Scholar
• GOLD. Executive Summary: Global Strategy for the Diagnosis, Management, and Prevention of COPD, Updated 2007
   Google Scholar
• Federal census data. Statistics Canada, Ottawa, ON 1996, Canada Health Canada
   Google Scholar
• CACI. The sourcebook of ZIP code demographics. CACI, Fairfax, Virginia 2002
   Google Scholar
• Omata M, Wakabayashi R, Kudoh S, Kida K. Correlation between bronchodilator responsiveness and quality of life in chronic obstructive pulmonary disease. Allergol Int 2007; 56: 15–22
   PubMedGoogle Scholar
• Perng D W, Wu C C, Su K C, Lee Y C, Perng R P, Tao C W. Inhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibility. Lung 2006; 184: 217–222
   PubMed Web of Science ®Google Scholar
• Wise R A, Kanner R E, Lindgren P, Connett J E, Altose M D, Enright P L, Tashkin D P. The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study. Chest 2003; 124: 449–458
   PubMed Web of Science ®Google Scholar
• Sayiner A, Aytemur Z A, Cirit M, Unsal I. Systemic glucocorticoids in severe exacerbations of COPD. Chest 2001; 119: 726–730
   PubMed Web of Science ®Google Scholar
• Thompson W H, Nielson C P, Carvalho P, Charan N B, Crowley J J. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996; 154: 407–412
   PubMed Web of Science ®Google Scholar
• Tsai C L, Griswold S K, Clark S, Camargo C A, Jr. Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation. J Gen Intern Med 2007; 22: 799–804
   PubMed Web of Science ®Google Scholar
• Ng T P, Niti M, Tan W C, Cao Z, Ong K C, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167: 60–67
   PubMed Web of Science ®Google Scholar
• Rennard S, Decramer M, Calverley P M, Pride N B, Soriano J B, Vermeire P A, Vestbo J. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002; 20: 799–805
   PubMed Web of Science ®Google Scholar
• Scharloo M, Kaptein A A, Schlosser M, Pouwels H, Bel E H, Rabe K F, Wouters E F. Illness perceptions and quality of life in patients with chronic obstructive pulmonary disease. J Asthma 2007; 44: 575–581
   PubMed Web of Science ®Google Scholar
• von Leupoldt A, Balewski S, Petersen S, Taube K, Schubert-Heukeshoven S, Magnussen H, Dahme B. Verbal descriptors of dyspnea in patients with COPD at different intensity levels of dyspnea. Chest 2007; 132: 141–147
   PubMed Web of Science ®Google Scholar
• Buist A S, McBurnie M A, Vollmer W M, Gillespie S, Burney P, Mannino D M, Menezes A M, Sullivan S D, Lee T A, Weiss K B, Jensen R L, Marks G B, Gulsvik A, Nizankowska-Mogilnicka E. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741–750
   PubMed Web of Science ®Google Scholar
• Menezes A M, Perez-Padilla R, Jardim J R, Muino A, Lopez M V, Valdivia G, Montes de Oca M, Talamo C, Hallal P C, Victora C G. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875–1881
   PubMed Web of Science ®Google Scholar
• Watson L, Vonk J M, Lofdahl C G, Pride N B, Pauwels R A, Laitinen L A, Schouten J P, Postma D S. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. Respir Med 2006; 100: 746–753
   PubMed Web of Science ®Google Scholar
• Seemungal T A, Donaldson G C, Bhowmik A, Jeffries D J, Wedzicha J A. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1608–1613
   PubMed Web of Science ®Google Scholar
• Tsai C L, Clark S, Cydulka R K, Rowe B H, Camargo C A, Jr. Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad Emerg Med 2007; 14: 6–14
   PubMed Web of Science ®Google Scholar